Oncology Views & Analysis

Views & Analysis

On the pulse of ASCO: pricing and clinical trial access

New survey data from MedPanel, compiled exclusively for pharmaphorum, has revealed US physicians’ thoughts on the topics set to dominate ASCO.

Oncology

ASCO Chicago 2019

Views & Analysis

ASCO 2019 and the future of oncology

The future of oncology is to be showcased at ASCO 2019 when the world’s leading cancer event returns to McCormick Place in Chicago.

Views & Analysis

ASCO 2019 Preview – in partnership with Kantar

ASCO’s 2019 conference is due to begin in just a few days’ time, highlighting the latest cutting edge cancer drugs and technology.

Views & Analysis

Oncology round-up: AZ and Daiichi score key trial win with b...

AZ and Daiichi Sankyo announced positive top-line results from the pivotal phase 2 DESTINY-Breast01 trial of trastuzumab deruxtecan, an antibody-drug conjugate, in patients with an advanced

Views & Analysis

Organoids: bringing life to precision medicine

Swiss-based biotech QGel is hoping to offer a novel approach to precision medicine by solving several of the current challenges with ‘organoids’, which can be used to test medicines on orga

On the pulse of ASCO: pricing and clinical trial access

ASCO Chicago 2019

ASCO 2019 and the future of oncology

ASCO 2019 Preview – in partnership with Kantar

Oncology round-up: AZ and Daiichi score key trial win with b...

Organoids: bringing life to precision medicine

Making direct-to-patient work, with Matt Wadyka

Using AI-driven synthetic personas to take your insights fur...

Views & Analysis

Editor's Picks